Boston Scientific wins Spanish clearance to buy B. Braun medical assets
( March 14, 2024, 11:33 GMT | Official Statement) -- MLex Summary: Boston Scientific Corporation can acquire the medical assets of B. Braun Group on condition of compliance with a package of commitments for five years, the Spanish competition authority has said. The transaction focuses on products to treat medical conditions such as fistula, and the CNMC was concerned that "portfolio effects" would "pose a barrier to the entry and the expansion of competitors." BSC has committed not to tie the procurement of certain products in its portfolio with other devices.The statement follows:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.